Charm Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML (NCT07751991) | Charm Therapeutics | 2026-08-01 |
Track Charm Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.